![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Correction
Correction
August 16, 2006
Celsion's Prolieve thermodilatation disposable catheter system discussed in an article in the Aug. 15 issue of Device Daily Bulletin, "Celsion Prostate Cancer Catheter Kits Back on the Market," is for treating benign prostatic hyperplasia. Changes in Celsion's manufacturing and inspection processes for the system were identified and initiated by the firm and the FDA approved implementation of the changes.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct